John E Wehrli

Title: John E Wehrli: Innovator in Pharmacokinetic-Based Drug Design

Introduction

John E Wehrli is a notable inventor based in Mountain View, California. He has made significant contributions to the field of pharmacokinetics, particularly in the design and selection of drug compounds. With a total of three patents to his name, Wehrli's work focuses on improving the efficiency and effectiveness of drug absorption and delivery.

Latest Patents

Wehrli's latest patents include a method for screening and producing compound libraries. This innovative method involves generating an in vivo absorption profile for test samples, which helps in producing a secondary compound library with desired absorption characteristics. Another significant patent is a pharmacokinetic-based design and selection tool, which predicts the absorption of administered compounds. This tool utilizes a physiologic-based simulation model and a differential equation solver to optimize drug design and predict drug efficacy.

Career Highlights

John E Wehrli is currently associated with Lion Bioscience AG, where he continues to advance his research in pharmacokinetics. His work has been instrumental in developing tools that aid in the design and selection of drugs, enhancing the overall drug development process.

Collaborations

Wehrli has collaborated with notable colleagues such as George M Grass and Glen D Leesman. These collaborations have further enriched his research and contributed to the advancements in the field of drug design.

Conclusion

John E Wehrli's innovative contributions to pharmacokinetics and drug design have established him as a key figure in the field. His patents reflect a commitment to improving drug efficacy and absorption, which is crucial for the development of effective medications.